Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride plus carboxytherapy versus finasteride plus PRF for male androgenetic alopecia
IRCT20260912071018N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of finasteride and platelet rich fibrin in androgenetic alopecia (AGA) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Patient age, Degree of alopecia and 3 more. Started Sep 2026; status: completed.
02
Drugs
finasterideplatelet rich fibrin
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20260912071018N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260912071018N1.